| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $57,365,303 ) (Continued on the next page) |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01ES032810 | A multicity study of wintertime inversions and acute cardiorespiratory health events in the western U.S. | 000 | 3 | NIH | 2/22/2023 | $538,557 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32HD104442 | Function of Kdm4dl-mediated heterochromatin removal in the preimplantation mouse embryo | 000 | 3 | NIH | 12/8/2022 | $69,802 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32HD104442 | Function of Kdm4dl-mediated heterochromatin removal in the preimplantation mouse embryo | 001 | 3 | NIH | 2/7/2023 | $1,990 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI139535 | Targeted depletion of programmed death-1 positive cells, a method that not only stops autoimmune attack but also preserves adaptive immunity | 000 | 4 | NIH | 2/6/2023 | $150,861 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01GM144719 | ?Conus venom peptides and their molecular targets: Using pharmaconomics and neuroethology as a framework for discovery? | 000 | 2 | NIH | 2/7/2023 | $574,453 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T32GM139805 | IMSD at the University of Utah (IMSD@U2) | 000 | 2 | NIH | 1/27/2023 | $219,809 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23HL157751 | A theory-based practice guide for creating patient education | 000 | 2 | NIH | 1/26/2023 | $149,623 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH126051 | Neuroplasticity-Based Computerized Cognitive Remediation (nCCR) for Treatment Resistant Late-Life Depression | 000 | 3 | NIH | 2/27/2023 | $1,469,147 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U24HL147018 | 2/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED) | 000 | 3 | NIH | 12/2/2022 | $467,393 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI143567 | Tyrosine Kinase inhibition: The New Front in HIV Cure Efforts | 000 | 5 | NIH | 10/26/2022 | $442,650 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T32GM139805 | IMSD at the University of Utah (IMSD@U2) | 001 | 2 | NIH | 3/1/2023 | $3,421 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM144241 | Novel functions for Sm-class RNAs in the regulation of gene expression | 000 | 2 | NIH | 1/10/2023 | $346,031 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K99GM144774 | Plasticity and Nitric Oxide Signaling: Identifying the Novel Adaptive Mechanisms Associated with Response to Hypoxia | 000 | 2 | NIH | 12/15/2022 | $116,059 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA259156 | Using Natural Language Processing and Crowdsourcing to Monitor and Evaluate Public Information and Communication Disparities about Colon Cancer Screening | 001 | 3 | NIH | 3/2/2023 | $474,710 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY031959 | Connectivity and function of inhibitory neurons in the primate visual cortex | 000 | 3 | NIH | 2/6/2023 | $96,905 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM134936 | Evolutionary innovations from host-microbe interactions | 000 | 4 | NIH | 1/10/2023 | $343,125 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DC017466 | Mechanisms of temporal selectivity in the anuran auditory midbrain | 000 | 5 | NIH | 11/15/2022 | $291,656 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DC017466 | Mechanisms of temporal selectivity in the anuran auditory midbrain | 001 | 5 | NIH | 1/12/2023 | $32,407 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY025780 | Stepwise Coordination of Eye Morphogenesis by Extracellular Matrix | 000 | 7 | NIH | 2/6/2023 | $381,250 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21CA263345 | A feasibility trial of functional precision cancer medicine to inform treatment selection in metastatic breast cancer | 000 | 2 | NIH | 3/14/2023 | $211,494 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA259686 | A tissue viability imaging biomarker for use in non-invasive breast cancer therapy | 000 | 2 | NIH | 2/1/2023 | $624,068 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 155 South 1452 East, INSCC Rm 350 | Salt Lake City | UT | 84112-8906 | SALT LAKE | USA | U3M45388 | Promoting Resilience and Mental Health Among Health Professional Workforce | 00 | 2 | HRSA | 12/6/2022 | $896,999 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31AG076312 | Telomere uncapping as a novel mechanism for endothelial cell senescence and age-related arterial dysfunction | 000 | 2 | NIH | 2/23/2023 | $47,694 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM141262 | Elucidating roles and mechanisms of double-stranded RNA-mediated pathways | 000 | 3 | NIH | 3/16/2023 | $603,900 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI147641 | CD8 T cell antigen recognition during chronic infection | 000 | 4 | NIH | 2/21/2023 | $646,886 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL146854 | The Roles of Neural Crest Derived Cardiomyocytes in Adult-Onset Heart Failure and Regeneration | 000 | 4 | NIH | 3/8/2023 | $642,835 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23HL148545 | Symptom Care at Home-Heart Failure: Developing and piloting a symptom monitoring and self-management coaching system for patients with heart failure | 000 | 3 | NIH | 3/1/2023 | $52,794 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG060395 | Impact of T cells on age-related vascular dysfunction: A translational approach | 000 | 5 | NIH | 2/17/2023 | $447,607 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HG012286 | Calypso: a web software system supporting team-based, longitudinal genomic diagnostic care | 000 | 2 | NIH | 1/23/2023 | $817,321 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HG012252 | New algorithms and tools for large-scale genomic analyses | 001 | 2 | NIH | 2/24/2023 | $62,502 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01MD017421 | SCALE UP Utah II: Community-Academic Partnership to Address COVID-19 Testing and Vaccination Among Utah Community Health Centers | 000 | 2 | NIH | 11/28/2022 | $1,142,661 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K01AG065623 | Developing and Testing the Enhancing Active Caregiver Training (EnACT) Intervention for Dementia Family Caregivers | 000 | 3 | NIH | 1/4/2023 | $132,468 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH122412 | Genetic risk discovery using WGS from a population-based resource of 10,000 suicide deaths with DNA | 000 | 4 | NIH | 1/20/2023 | $381,346 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T35HL007744 | Short-term Training: Students in Health Professional Schools | 000 | 28 | NIH | 3/15/2023 | $106,968 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HG012252 | New algorithms and tools for large-scale genomic analyses | 000 | 2 | NIH | 1/25/2023 | $562,530 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21NS125519 | Exploring the role of the protocadherin CELSR3 in Tourette syndrome | 001 | 2 | NIH | 1/31/2023 | $19,062 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21DC019437 | Understanding the effects of listening effort on sentence processing and memory in sensorineural hearing loss: Evidence from simultaneous electrophysiology and pupillometry | 000 | 2 | NIH | 2/8/2023 | $152,500 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK126903 | Validation and Identification of Genetic Variants in Peyronie's and Dupuytren's Disease that Predispose to Fibrosis and Inflammation | 000 | 2 | NIH | 1/13/2023 | $551,672 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01ES032028 | The influence of multiple environmental exposures on suicide risk | 000 | 3 | NIH | 3/3/2023 | $617,097 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA244583 | A Leukemia Cell-Specific Coiled-Coil Protein for Treatment of Chronic Myeloid Leukemia | 000 | 3 | NIH | 1/4/2023 | $313,959 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM136430 | Development and Application of Nicotinic Acetylcholine Receptor Targeted Peptides for Biomedical Research | 000 | 4 | NIH | 1/18/2023 | $404,889 |
| | 2023 | 2023 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K08HS026530 | Engaging Hospitalists to Improve Antibiotic Prescribing at Hospital Discharge | 001 | 5 | AHRQ | 3/15/2023 | $153,274 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K08CA234431 | Competition, Bundled Care Payment, and Low-Value Cancer Care | 000 | 5 | NIH | 11/10/2022 | $261,328 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI136963 | Microbiota Specific T Cell Selection | 000 | 5 | NIH | 10/25/2022 | $341,431 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA212415 | Transcriptional Regulation of Lung Cancer Identity | 001 | 6 | NIH | 12/29/2022 | $365,057 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS122184 | Personalized Profiles of Pathology in Pediatric Traumatic Brain Injury | 000 | 2 | NIH | 12/7/2022 | $574,295 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32GM140740 | Neurotropism in a naturally occurring enterovirus infection | 000 | 2 | NIH | 11/18/2022 | $67,582 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DC019127 | Regulation of inner ear development by FGF signals and effectors | 000 | 3 | NIH | 1/20/2023 | $414,062 |
| | 2023 | 2023 | UNIVERSITY OF UTAH, THE | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA246716 | Drug-Free Macromolecular Therapeutics | 000 | 12 | NIH | 2/6/2023 | $341,867 |
|
| Loading… |
|
